Inhibition of Human Neutrophil Functions In Vitro by Multiple Sclerosis Disease-Modifying Therapies

There is a growing optimism about the potential of new disease-modifying therapies (DMTs) in the management of relapsing-remitting multiple sclerosis (RRMS) patients. However, this initial enthusiasm has been tempered by evidence indicating that multiple sclerosis (MS) patients undergoing DMT may be...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Clin Med
Prif Awduron: Scutera, Sara, Musso, Tiziana, Cavalla, Paola, Piersigilli, Giorgia, Sparti, Rosaria, Comini, Sara, Vercellino, Marco, Cuffini, Anna Maria, Banche, Giuliana, Allizond, Valeria
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: MDPI 2020
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7692529/
https://ncbi.nlm.nih.gov/pubmed/33147889
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9113542
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg